These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10798203)

  • 1. [Factors determining the modality selection in dialysis].
    Kessler M; Chanliau J
    Nephrologie; 2000; 21(2):45-6. PubMed ID: 10798203
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary on the highlights of the epidemiology of renal replacement therapy in Central and Eastern Europe.
    Viklicky O; Pokorna E; Vitko S;
    Nephrol Dial Transplant; 2006 Jul; 21(7):2025-6; author reply 2026. PubMed ID: 16735390
    [No Abstract]   [Full Text] [Related]  

  • 3. [State of chronic dialysis in France on 31 December 1979. Chronic hemodialysis, peritoneal dialysis, equipment, number of patients treated].
    Méry JP
    Nephrologie; 1980; 1(3):121-5. PubMed ID: 7290295
    [No Abstract]   [Full Text] [Related]  

  • 4. Highlights of the epidemiology of renal replacement therapy in Central and Eastern Europe.
    Rutkowski B
    Nephrol Dial Transplant; 2006 Jan; 21(1):4-10. PubMed ID: 16280373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of peritoneal dialysis in renal replacement therapy: an update on medical aspects.
    Yao Q; Wang X; Chung SH; Pecoits-Filho R; Stenvinkel P; Wang T; Heimbürger O; Lindholm B
    Panminerva Med; 2005 Mar; 47(1):19-30. PubMed ID: 15985974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal dialysis or hemodialysis? A dilemma for the nephrologist.
    Shahab I; Khanna R; Nolph KD
    Adv Perit Dial; 2006; 22():180-5. PubMed ID: 16983966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modality selection.
    Diaz-Buxo JA
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S112-7. PubMed ID: 11443757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Factors determining the choice of a modality of treatment by dialysis: a study of nine dialysis centers].
    Bataille P; Coevoet B; Cuvelier D; Descoeudres C; Drüeke T; Moynot A; Poignet JL; Ryckelynck JP; Stroumza P
    Nephrologie; 2000; 21(2):57-63. PubMed ID: 10798205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Methods used in the treatment of chronic renal insufficiency in Andalucia: I. Influence of the patient's characteristics].
    Gentil MA; Rivas A; Ramos B; del Castillo D; Milán JA; Real Polo M; Fernández E; Torán D; López J; Martín Govantes JJ; Campos T
    Nefrologia; 2000; 20 Suppl 5():64-9. PubMed ID: 11190109
    [No Abstract]   [Full Text] [Related]  

  • 10. Public-private partnership in Hungarian dialysis care.
    Boncz I; Sebestyén A; Pintér I
    Nephrol Dial Transplant; 2006 Jul; 21(7):2024-5; author reply 2025. PubMed ID: 16644780
    [No Abstract]   [Full Text] [Related]  

  • 11. An analysis of the effectiveness and benefits of peritoneal dialysis and haemodialysis using Nigerian made PD fluids.
    Arogundade FA; Ishola DA; Sanusi AA; Akinsola A
    Afr J Med Med Sci; 2005 Sep; 34(3):227-33. PubMed ID: 16749353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a computer-aided diagnosis system for a new modality of renal replacement therapy: an integrated approach combining both peritoneal dialysis and hemodialysis.
    Hamada H; Namoto S; Yamada R; Yamashita AC; Ishizaki M; Okamoto M
    Comput Biol Med; 2005 Dec; 35(10):845-61. PubMed ID: 16310010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of a pre-dialysis education programme (PDEP) on the mode of renal replacement therapy.
    Goovaerts T; Jadoul M; Goffin E
    Nephrol Dial Transplant; 2005 Sep; 20(9):1842-7. PubMed ID: 15919693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. End-stage renal disease therapy: an American success story.
    Friedman EA
    JAMA; 1996 Apr; 275(14):1118-22. PubMed ID: 8601932
    [No Abstract]   [Full Text] [Related]  

  • 15. Dialysis modality distribution in the United States.
    Mendelssohn DC; Blake PG; Burkart J; Golper T; Oreopoulous D
    Am J Kidney Dis; 2001 Jun; 37(6):1330-1. PubMed ID: 11382710
    [No Abstract]   [Full Text] [Related]  

  • 16. III. Treatment modalities for ESRD patients.
    Am J Kidney Dis; 1999 Aug; 34(2 Suppl 1):S51-62. PubMed ID: 10431002
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal replacement therapy. 1-1. Introduction and review of dialysis and transplantation today.
    Stevens E
    Nurs Times; 1982 Apr 28-May 4; 78(17):700-4. PubMed ID: 7043409
    [No Abstract]   [Full Text] [Related]  

  • 18. Financial Barriers to the Optimal Use of Peritoneal Dialysis in France and Europe, as in the United States.
    Rostoker G; Issad B
    J Am Soc Nephrol; 2022 Nov; 33(11):2125-2126. PubMed ID: 36041789
    [No Abstract]   [Full Text] [Related]  

  • 19. Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders.
    Bajo MA; del Peso G; Jiménez V; Aguilera A; Villar A; Jiménez C; Selgas R
    Adv Perit Dial; 2000; 16():170-3. PubMed ID: 11045286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residual renal function: the delicate balance between benefits and risks.
    Canaud B
    Nephrol Dial Transplant; 2008 Jun; 23(6):1801-5. PubMed ID: 18344238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.